Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-28

Clinical Trial Update: A Randomized, Controlled Trial Comparing the Use of a Biodegradable Temporizing Matrix to Cadaver Skin in the Reconstruction of Hidradenitis Suppurativa Excisions [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial compares a biodegradable temporizing matrix to cadaver skin for reconstructing hidradenitis suppurativa excisions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Joseph M. Still Research Foundation, Inc. | Conditions: Hidradenitis Suppurativa | Phase 4 | Status: UNKNOWN